The market ignored the numbers and bought the strategy instead.
Economy
A Coterra merger, $90+ oil, and a 59% EPS jump all converge on one date.
The CFO already told you Q2 billing growth is running above a three-year high.
One of the S&P 500’s top stocks of 2026 just entered correction territory. The fundamental case hasn’t...
An 86% EPS beat today just made insurance the most interesting trade in the market.
A $10B Crinetics deal, a fifth commercial pillar, and Q2 earnings that will define the acquisition thesis.
Record profit, a $265B US bet, and a market asking the wrong question.
A record-breaking Q2 beat just sent shares surging 7%. Here's why the real story runs deeper.
America's aging population isn't just a healthcare story. It's a home infrastructure story.
Mounjaro sales up 125% in Q1. A new pill just launched. Q2 earnings could reset the story...
